RMD logo

RMD

ResMed Inc.

$274.41
+$1.22(+0.45%)
80
Overall
60
Value
100
Tech
--
Quality
Market Cap
$39.91B
Volume
549.21K
52W Range
$199.92 - $293.81
Target Price
$290.92
Order:

Income Statement

MetricTrendChart
2016
Jun
2017
Jun
2018
Jun
2019
Jun
2020
Jun
2021
Jun
2022
Jun
2023
Jun
2024
Jun
2025
Jun
REVENUE
Total Revenue
$1.8B$2.1B$2.3B$2.6B$3.0B$3.2B$3.6B$4.2B$4.7B$5.1B
Total Revenue
$1.8B$2.1B$2.3B$2.6B$3.0B$3.2B$3.6B$4.2B$4.7B$5.1B
COST OF GOODS SOLD
Cost of Revenue
$772.2M$865.0M$978.0M$1.1B$1.2B$1.4B$1.5B$1.8B$2.0B$2.1B
GROSS PROFIT
Gross Profit
$1.1B$1.2B$1.4B$1.5B$1.7B$1.8B$2.0B$2.4B$2.7B$3.1B
OPERATING EXPENSES
Operating Expenses
$637.5M$775.9M$820.3M$914.8M$908.1M$935.4M$1.0B$1.2B$1.3B$1.4B
Research & Development
$118.7M$144.5M$155.1M$180.7M$201.9M$225.3M$253.6M$287.6M$307.5M$331.3M
Research Expense
$118.7M$144.5M$155.1M$180.7M$201.9M$225.3M$253.6M$287.6M$307.5M$331.3M
Selling, General & Administrative
$488.1M$554.0M$600.4M$645.0M$676.7M$670.4M$737.5M$874.0M$917.1M$991.0M
General & Administrative Expenses
$488.1M$554.0M$600.4M$645.0M$676.7M$670.4M$737.5M$874.0M$917.1M$991.0M
Salaries & Wages
$-25.0M$-20.1M$-17.1M$-26.7M$-39.5M$-23.3M$-29.3M------
Depreciation & Amortization
------$42.5M$49.6M$45.1M$39.6M$30.4M$33.0M$32.1M
Depreciation & Amortization
------$42.5M$49.6M$45.1M$39.6M$30.4M$33.0M$32.1M
Amortization
$1.1B$1.1B$1.1B$42.5M$49.6M$45.1M$39.6M$30.4M$33.0M$32.1M
Other Operating Expenses
$-23.9M$-46.6M$-46.4M$-38.5M$-30.1M$-31.1M$35.3M------
OPERATING INCOME
Operating income
$429.0M$425.8M$541.8M$579.3M$809.7M$903.7M$1.0B$1.1B$1.3B$1.7B
EBITDA
$537.6M$559.1M$669.6M$705.8M$990.4M$1.1B$1.2B$1.3B$1.5B$1.9B
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$11.2M$28.2M$28.4M$36.2M$40.4M$23.6M$22.3M$47.4M$45.7M$-4.1M
Intinc
$16.9M$17.1M$16.4M$2.3M$1.0M$362.0K--------
Net Non-Operating Interest Income/Expense
$5.7M$-11.2M$-12.0M$-33.9M$-39.4M$-23.6M$-22.3M$-47.4M$-45.7M$4.1M
Gain on Sale of Securities
----------$14.5M$-12.2M$9.9M$-4.0M$-10.3M
Other Income/Expense
$-5.0M$-4.1M$8.5M$26.6M$37.2M$-3.6M$-19.4M$3.1M$9.4M$11.9M
Other Special Charges
$5.0M$4.1M$-8.5M$-10.7M$-12.2M$301.0K$3.2M$-5.7M$-3.5M$-5.3M
SPECIAL ITEMS
Restructring And Mn A Income
$6.9M$12.4M$18.4M$9.4M--$8.7M--$-11.1M$64.2M--
Special Income Charges
$-6.9M$-20.9M$-18.4M$-50.6M$600.0K$-8.7M--$11.1M$-64.2M--
Other Impairment Of Capital Assets
$2.8M$2.0M$11.6M$15.0M$-14.5M$-14.5M$3.2M------
PRE-TAX INCOME
EBIT
$450.8M$447.0M$549.7M$555.0M$809.1M$912.4M$982.8M$1.1B$1.3B$1.7B
Pre-Tax Income
$439.6M$418.7M$521.3M$518.8M$733.1M$883.7M$960.5M$1.1B$1.3B$1.7B
INCOME TAX
Tax Provision
$87.2M$76.5M$205.7M$114.3M$111.4M$409.2M$181.0M$204.1M$243.8M$276.8M
NET INCOME
Net Income
$352.4M$342.3M$315.6M$404.6M$621.7M$474.5M$779.4M$897.6M$1.0B$1.4B
Net Income (Continuing Operations)
$352.4M$342.3M$315.6M$404.6M$621.7M$474.5M$779.4M$897.6M$1.0B$1.4B
Net Income (Discontinued Operations)
$352.4M$342.3M$315.6M$404.6M$621.7M$474.5M$779.4M$897.6M$1.0B$1.4B
Net Income (Common Stockholders)
$400.3M$435.4M$408.4M$481.7M$621.7M$474.5M$779.4M$897.6M$1.0B$1.4B
Normalized Income
$292.5M$315.1M$441.9M$481.6M$564.0M$706.8M------$1.7B
TOTALS
Total Expenses
$1.4B$1.6B$1.8B$2.0B$2.1B$2.3B$2.5B$3.1B$3.3B$3.4B
SHARE & EPS DATA
Average Shares Outstanding
$140.2M$141.4M$142.8M$143.1M$144.3M$145.3M$146.1M$146.8M$147.0M$146.7M
Average Shares Outstanding (Diluted)
$141.7M$142.5M$144.0M$144.5M$145.7M$146.5M$147.0M$147.5M$147.6M$147.3M
Shares Outstanding
$140.7M$142.2M$142.7M$143.7M$144.9M$145.7K$146.4M$147.1M$146.9M$146.4M
Basic EPS
$2.51$2.42$2.21$2.83$4.31$3.27$5.34$6.12$6.94$9.55
Basic EPS (Continuing Operations)
$2.51$2.42$2.21$2.83$4.31$3.27$5.34$6.12$6.94$9.55
Diluted EPS
$2.49$2.4$2.19$2.8$4.27$3.24$5.3$6.09$6.92$9.51
Diluted EPS (Continuing Operations)
$2.49$2.4$2.19$2.8$4.27$3.24$5.3$6.09$6.92$9.51
Dividend Per Share
$1.2$1.32$1.4$1.48$1.56$1.56$1.68$1.76$1.92$2.12
OTHER METRICS
Acquisition Expense
$5.3M$10.1M--$6.1M----$1.9M$10.9M--$2.0M
Earnings from equity interest
$-168.1M$-186.3M$-199.5M$-15.8M$-25.1M$-11.2M$-8.5M$-7.3M$-1.8M$3.6M
Earnings From Equity Interest Net Of Tax
$-168.1M$-186.3M$-199.5M$-15.8M$-25.1M$-11.2M$-8.5M$-7.3M$-1.8M$3.6M
Loss And Loss Adjustment Expected Incurred
--------$6.6M$8.2M$2.1M------
Non Recurring Operation Expense
--$8.5M--$41.2M$-600.0K----------
Other Gand A
$488.1M$554.0M$600.4M$645.0M$676.7M$670.4M$737.5M$874.0M$917.1M$991.0M
Rent And Landing Fees
$17.4M$20.1M$21.1M$23.4M------------
Restruct
$6.9M$12.4M$18.4M$9.4M--$8.7M--$-11.1M$64.2M--

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2RMD$274.41+0.4%549.21K
3
4
5
6

Get ResMed Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.